Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.05 EUR | +2.96% | +2.32% | +17.41% |
18/04 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
07/03 | Van Lanschot Kempen Plans Early Redemption of EUR100 Million Notes | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 909.9 | 881.4 | 1,397 | - | - |
Enterprise Value (EV) 1 | 909.9 | 881.4 | 1,397 | 1,397 | 1,397 |
P/E ratio | 6.57 x | 11.5 x | 12.2 x | 11.2 x | 10.8 x |
Yield | 9.09% | 7.99% | 7.93% | 6.07% | 6.34% |
Capitalization / Revenue | 1.53 x | 1.47 x | 2.06 x | 2 x | 1.94 x |
EV / Revenue | 1.53 x | 1.47 x | 2.06 x | 2 x | 1.94 x |
EV / EBITDA | - | - | - | - | - |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | - | 1.15 x | 1.1 x | 1.06 x |
Nbr of stocks (in thousands) | 41,360 | 40,247 | 42,262 | - | - |
Reference price 2 | 22.00 | 21.90 | 33.05 | 33.05 | 33.05 |
Announcement Date | 24/02/22 | 23/02/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 594.7 | 599.7 | - | 676.4 | 699.7 | 720.9 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | 173.5 | 146.6 | - | 165 | 164 | 168 |
Operating Margin | - | 29.17% | 24.45% | - | 24.39% | 23.44% | 23.3% |
Earnings before Tax (EBT) 1 | - | 178.5 | - | - | 155.4 | 168.2 | 177.2 |
Net income 1 | 43.01 | 143.8 | 84.3 | 125.2 | 114.7 | 123 | 128.7 |
Net margin | - | 24.18% | 14.06% | - | 16.96% | 17.59% | 17.85% |
EPS 2 | 1.050 | 3.350 | 1.900 | - | 2.705 | 2.955 | 3.050 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | 2.000 | 1.750 | - | 2.620 | 2.005 | 2.095 |
Announcement Date | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|
Net sales 1 | 269.3 | 325.4 | 293.1 | 306.6 | 315.7 | 337.5 | 342.9 |
EBITDA | - | - | - | - | - | - | - |
EBIT | 68.8 | 104.7 | 69.5 | 77.1 | 73.4 | - | - |
Operating Margin | 25.55% | 32.18% | 23.71% | 25.15% | 23.25% | - | - |
Earnings before Tax (EBT) 1 | 74 | 104.5 | 60.6 | - | 71.3 | 78.2 | 81.5 |
Net income 1 | 58.3 | 85.5 | - | - | 48.4 | 56 | 57.6 |
Net margin | 21.65% | 26.28% | - | - | 15.33% | 16.59% | 16.8% |
EPS 2 | 1.339 | 2.010 | 1.112 | - | 1.170 | 1.360 | 1.400 |
Dividend per Share | - | 2.000 | - | 1.750 | - | - | - |
Announcement Date | 26/08/21 | 24/02/22 | 25/08/22 | 23/02/23 | 24/08/23 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | 12.5% | 6.04% | - | 8.95% | 9.35% | 9.9% |
ROA (Net income/ Total Assets) | - | 0.87% | 0.51% | - | 0.67% | 0.67% | 0.69% |
Assets 1 | - | 16,510 | 16,663 | - | 17,122 | 18,366 | 18,646 |
Book Value Per Share 2 | - | - | - | - | 28.90 | 30.10 | 31.20 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.41% | 1.49B | |
+4.75% | 8.74B | |
+13.83% | 3.48B | |
-36.31% | 2.96B | |
+13.29% | 2.52B | |
+14.51% | 2.39B | |
+42.63% | 2.17B | |
+12.44% | 1.49B | |
+9.13% | 1.42B | |
0.00% | 1.02B |
- Stock Market
- Equities
- VLK Stock
- Financials Van Lanschot Kempen N.V